Vancomycin

Status:: Green
Decision Date:: August 2021

Comments

GREEN 1^st line for mild/moderate C. difficile infection. (Decision date - June 2022)

See NICE/PHE - Summary of antimicrobial prescribing guidance – managing common infections for further details.

Local C.Diff guideline